TLDR: Helfie AI, a global mobile health platform, has been shortlisted for the prestigious Prix Galien USA 2025 prize in the ‘Best Digital Health Solution’ category. The company aims to revolutionize preventative healthcare by providing individuals with a personal health AI platform that offers intelligent insights and continuous monitoring via mobile devices, addressing the lack of participation in preventative healthcare and under-utilization of health data. The winners will be announced on October 30, 2025, in New York City.
Melbourne, Australia – August 18, 2025 – Helfie AI, a pioneering global mobile health platform, has been officially named a finalist for the esteemed Prix Galien USA 2025 prize in the “Best Digital Health Solution” category. This recognition positions Helfie AI among the leading innovators in life sciences, with the Prix Galien often referred to as the “Nobel Prize for biopharmaceutical research and digital health innovation.”
Helfie AI’s core mission is to fundamentally reshape preventative healthcare by equipping individuals with their own personal health AI platform. This innovative solution enables users to check key health conditions, such as cardiovascular, lung, sexual, and skin health, receive intelligent insights, and engage in persistent health monitoring, all through their mobile devices within seconds and for minimal cost. The platform is designed to ensure that access to vital health intelligence is not limited by geography, income, or existing infrastructure.
George Tomeski, CEO of Helfie AI, expressed his honor regarding the nomination, stating, “To be nominated for the Prix Galien awards is an honor and a testament to the impact Helfie AI can have on preventative healthcare access to millions of individuals worldwide.” He further elaborated on the company’s vision: “We see healthcare as a living network and not a series of isolated interactions when someone falls ill. It should be a continuous, ambient intelligence woven into daily life, which is the basis for how we’ve built Helfie AI. We’re creating a healthcare revolution emphasizing data ownership, universal access, and freedom of choice, enabling early disease detection and prevention for all 8 billion of us.”
The accessibility offered by Helfie AI holds significant potential to reduce the staggering $7 trillion spent annually on treating preventable conditions. The platform guides users with clear next steps, facilitates connections to medical care when necessary, supports interaction across numerous health conditions, and allows for sharing AI findings with caregivers and doctors.
Founded in Melbourne, Australia, in 2021, Helfie AI has rapidly expanded its operations across Europe, North America, Africa, and Asia, establishing multiple active B2B partnerships with top-tier companies. The company directly addresses two critical challenges in healthcare: the widespread lack of participation in preventative healthcare and the under-utilization of health data. Helfie AI believes that active participation in preventative health and the effective utilization of health data can dramatically improve the quality and longevity of human life.
Also Read:
- CelHive Ascends to Unicorn Status, Revolutionizing AI-Powered Workforces and Digital Productivity
- AI Innovator Waddle Secures Major New Contract on August 18th
The Prix Galien USA Awards Ceremony, where the winners will be announced, is scheduled for October 30, 2025, at the American Museum of Natural History in New York City. An independent jury, comprising renowned scientists, industry leaders, and Nobel Laureates, meticulously reviews hundreds of global entries. To qualify for nomination, products must have received U.S. Food and Drug Administration (FDA) approval for marketing within the last five years and demonstrate substantial potential to enhance human health.
